In vivo evaluation of a hollow fiber liver assist device

Hepatology

Volumn 21, Issue 2, 1995, Pages 460-469

  Jauregui, Hugo O ^a,b   Mullon, Claudy J P ^c   Trenkler, Donna ^a   Naik, Sharda ^a   Santangini, Henry ^a   Press, Philip ^c   Muller, Thomas E ^c   Solomon, Barry A ^c  

^a RHODE ISLAND HOSPITAL   (United States)

^b Laboratory Medicine   (United States)

^c W R GRACE AND CO CONN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; GALACTOSAMINE; LIDOCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL LIVER; CONTROLLED STUDY; DISEASE COURSE; DRUG DETOXIFICATION; HEPATIC ENCEPHALOPATHY; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMAL; ARTIFICIAL ORGANS; DIAZEPAM; EVALUATION STUDIES; EXTRACORPOREAL CIRCULATION; GALACTOSAMINE; HEPATIC ENCEPHALOPATHY; LIDOCAINE; LIVER; MALE; RABBITS;

EID: 0028958073     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90108-6     Document Type: Article

References (55)

1. Orthotopic liver transplantation for acute and subacute hepatic failure in adults
2. Fulminant hepatic failure
3. The role of transplantation in liver disease
4. Liver transplantation
5. Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries
6. Neonatal hepatocyte culture on artificial capillaries: a model for drug metabolism and the artificial liver
7. Adult rat hepatocyte cultures as the cellular component of an artificial hybrid liver
8. New method of hepatocyte transplantation and extracorporeal liver support
9. Reversal of fulminant hepatic failure using an extracorporeal liver assist device
10. Improved liver function following treatment with an extracorporeal liver assist device
11. Modulation of the liver specific phenotype in the human hepatoblastoma line HEP G2
12. Long term cultures of adult mammalian hepatocytes in hollow fibers as the cellular component of extra-corporeal (hybrid) liver assist devices
13. Development of a hybrid bioartificial liver
14. Primary cultures of rat hepatocytes in hollow fiber chambers
15. A model of fulminant hepatic failure in the rabbit
16. The rat with portacaval shunt: an animal model with chronic hepatic failure
17. Lowering of plasma free tryptophan in normal and portacaval shunt dogs
18. Induction of unequivocal encephalopathy in the portacaval shunted rat
19. Preparation of isolated rat liver cells
20. Phenobarbital induction of cytochromes P450
21. Trypan blue dye uptake and lactate dehydrogenase in adult rat hepatocytes-freshly isolated cells, cell suspensions, and primary monolayer cultures
22. Xenobiotic induction of P-450 PB-4 (IIB1) and P-450c (JA1) and associated monooxygenase activities in primary cultures of adult rat hepatocytes
23. Lidocaine metabolism as an indicator of liver function
24. Practical stereological methods for morphometric cytology
25. Visual and auditory evoked potentials in galactosamine-induced fulminant hepatic failure
26. Subdivision of hexagonal liver lobules into a structural and functional unit; role in hepatic physiology and pathology
27. Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy
28. Attachment and long term survival of adult rat hepatocytes in primary monolayer cultures; comparison of different substrata and tissue culture media formulations
29. Drug metabolism and hepatotoxicity
30. Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordiazepam but not N-dealkylation of diazepam and temazepam
31. Specific metabolic pathway in vitro of pinazepam and diazepam by liver microsomal enzymes of different animal species
32. Expression of five forms of microsomal cytochrome P450 in primary cultures of rabbit hepatocytes treated with various classes of inducers
33. Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients
34. Evaluation of quantitative liver function tests in liver donors
35. The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, and man
36. Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4
37. Lidocaine metabolism by rabbit liver homogenate and detection of a new metabolite
38. Pharmacokinetic analysis verifies P450 function during in vitro and in vivo application of a bioartificial liver
39. Ammonia: key factor in the pathogenesis of hepatic encephalopathy
40. Hepatic encephalopathy
41. “Endogenous” benzodiazepine activity in physiological fluids of patients with hepatic encephalopathy
42. Molecular weight cut-offs of hollow fiber liver assist devices may impose restrictions in the metabolism of toxic products
43. Brain edema in rabbits with galactosamine-induced fulminant hepatitis
44. Prediction of fatality in fulminant hepatic failure
45. Cholic acid conjugation test and quantitative liver function in acute liver failure
46. Blood ammonia levels in cerebral dysfunction
47. Hepatic encephalopathy and cerebral edema
48. Fulminant hepatic failure: the role of liver transplantation as primary therapy
49. The liver during and after fulminant hepatitis
50. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage
51. The role of lactate in the pathogenesis of brain edema in acute liver failure
52. Liver failure and quantitative liver function